SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-19-220567
Filing Date
2019-08-14
Accepted
2019-08-14 08:00:32
Documents
2
Period of Report
2019-08-14
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d774245d8k.htm 8-K 19431
2 EX-99.1 d774245dex991.htm EX-99.1 66744
  Complete submission text file 0001193125-19-220567.txt   87362
Mailing Address 3 PRESTON COURT BEDFORD MA 01730
Business Address 3 PRESTON COURT BEDFORD MA 01730 781-430-8200
Stoke Therapeutics, Inc. (Filer) CIK: 0001623526 (see all company filings)

IRS No.: 471144582 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38938 | Film No.: 191022876
SIC: 2834 Pharmaceutical Preparations